-
Something wrong with this record ?
Differentiated expression of the lactate dehydrogenase subunit M in pleural fluids of neoplastic aetiology
J Kotyza, D Havel, V Kulda, K Bunatova, M Pesek
Language English Country Norway
NLK
Medline Complete (EBSCOhost)
from 1998-05-19 to 1 year ago
- MeSH
- Biomarkers metabolism MeSH
- Financing, Organized MeSH
- Isoenzymes blood metabolism MeSH
- L-Lactate Dehydrogenase blood metabolism MeSH
- Middle Aged MeSH
- Humans MeSH
- Inflammation Mediators analysis MeSH
- Neoplasm Metastasis MeSH
- Lung Neoplasms enzymology pathology ultrastructure MeSH
- Pleural Effusion enzymology etiology MeSH
- Protein Subunits blood metabolism MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
OBJECTIVE: An anaerobic type of glycolysis exemplified by hyperproduction of the lactate dehydrogenase (LDH) subunit M has been detected in lung tumours, while a similar pattern has been found in concomitant pleural effusions (PE). The aim of this study was to verify the presence of the LDH subunit M in PEs of different aetiology and to compare its expression with markers of inflammation. MATERIAL AND METHODS: LDH isoenzymes were estimated and the LDH5/LDH1 coefficient was calculated in paraneoplastic PEs (n = 99), including subgroups with a different tumour ultrastructure, origin and pleural involvement. The expression pattern was compared with parainflammatory PEs (n = 21), transudates (n = 16) and with the expression of 13 inflammatory markers in PEs. RESULTS: The LDH5/LDH1 coefficient was higher in PEs associated with non-small-cell lung cancer (NSCLC) and with pleura-invading tumours, and lower in PEs of small-cell lung cancer and tumours without a confirmed pleural involvement. The LDH5/LDH1 coefficient positively correlated with uPA, IL-8, IL-10, sICAM, sVCAM, MPO and MMP-9. CONCLUSIONS: In accordance with inflammatory markers, it appears that the expression of LDH and its isoenzymes in PEs reflects the host reaction in pleural space and, in NSCLC, may also feature the anaerobic phenotype of cancer cells.
- 000
- 02225naa 2200469 a 4500
- 001
- bmc11006069
- 003
- CZ-PrNML
- 005
- 20150818110618.0
- 008
- 110331s2009 no e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a no
- 100 1_
- $a Kotyza, Jaromír, $d 1940- $7 jn20000401437
- 245 10
- $a Differentiated expression of the lactate dehydrogenase subunit M in pleural fluids of neoplastic aetiology / $c J Kotyza, D Havel, V Kulda, K Bunatova, M Pesek
- 314 __
- $a Institute of Biochemistry, Medical Faculty in Pilsen, Charles University, The Czech Republic. jaromir.kotyza@lfp.cuni.cz
- 520 9_
- $a OBJECTIVE: An anaerobic type of glycolysis exemplified by hyperproduction of the lactate dehydrogenase (LDH) subunit M has been detected in lung tumours, while a similar pattern has been found in concomitant pleural effusions (PE). The aim of this study was to verify the presence of the LDH subunit M in PEs of different aetiology and to compare its expression with markers of inflammation. MATERIAL AND METHODS: LDH isoenzymes were estimated and the LDH5/LDH1 coefficient was calculated in paraneoplastic PEs (n = 99), including subgroups with a different tumour ultrastructure, origin and pleural involvement. The expression pattern was compared with parainflammatory PEs (n = 21), transudates (n = 16) and with the expression of 13 inflammatory markers in PEs. RESULTS: The LDH5/LDH1 coefficient was higher in PEs associated with non-small-cell lung cancer (NSCLC) and with pleura-invading tumours, and lower in PEs of small-cell lung cancer and tumours without a confirmed pleural involvement. The LDH5/LDH1 coefficient positively correlated with uPA, IL-8, IL-10, sICAM, sVCAM, MPO and MMP-9. CONCLUSIONS: In accordance with inflammatory markers, it appears that the expression of LDH and its isoenzymes in PEs reflects the host reaction in pleural space and, in NSCLC, may also feature the anaerobic phenotype of cancer cells.
- 650 _2
- $a biologické markery $x metabolismus $7 D015415
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mediátory zánětu $x analýza $7 D018836
- 650 _2
- $a izoenzymy $x krev $x metabolismus $7 D007527
- 650 _2
- $a L-laktátdehydrogenasa $x krev $x metabolismus $7 D007770
- 650 _2
- $a nádory plic $x enzymologie $x patologie $x ultrastruktura $7 D008175
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a metastázy nádorů $7 D009362
- 650 _2
- $a pleurální výpotek $x enzymologie $x etiologie $7 D010996
- 650 _2
- $a podjednotky proteinů $x krev $x metabolismus $7 D021122
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Havel, David $7 mzk2008459054
- 700 1_
- $a Kulda, Vlastimil, $d 1979- $7 xx0138688
- 700 1_
- $a Buňatová, Karin, $d 1973-2012 $7 xx0074088
- 700 1_
- $a Pešek, Miloš, $d 1950- $7 jn20021014008
- 773 0_
- $t Scandinavian Journal of Clinical & Laboratory Investigation $w MED00010597 $g Roč. 69, č. 1 (2009), s. 73-78 $x 0036-5513
- 910 __
- $a ABA008 $b x $y 2 $z 0
- 990 __
- $a 20110414095831 $b ABA008
- 991 __
- $a 20150818110725 $b ABA008
- 999 __
- $a ok $b bmc $g 833698 $s 698158
- BAS __
- $a 3
- BMC __
- $a 2009 $b 69 $c 1 $d 73-78 $m Scandinavian journal of clinical & laboratory investigation $n Scand J Clin Lab Invest $x MED00010597 $i 0036-5513
- LZP __
- $a 2011-1B09/dkme